Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic

See also
Status	Clinical Trial	Phase
Completed	`NCT01922076` - Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas	Phase 1
Recruiting	`NCT05476939` - Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0	Phase 3
Terminated	`NCT03330197` - A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG	Phase 1/Phase 2
Terminated	`NCT03690869` - REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma	Phase 1/Phase 2
Active, not recruiting	`NCT02992015` - Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma	Early Phase 1
Terminated	`NCT01182350` - Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)	Phase 2
Recruiting	`NCT04837547` - PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy	Phase 1
Active, not recruiting	`NCT04911621` - Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma	Phase 1/Phase 2
Not yet recruiting	`NCT06333899` - Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion	Early Phase 1
Completed	`NCT00879437` - Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma	Phase 2
Active, not recruiting	`NCT02420613` - Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma	Phase 1
Completed	`NCT03086616` - CED With Irinotecan Liposome Injection Using Real Time Imaging in Children With Diffuse Intrinsic Pontine Glioma (DIPG) (PNOC 009)	Phase 1
Recruiting	`NCT01837862` - A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas	Phase 1/Phase 2
Not yet recruiting	`NCT06093165` - RE-irradiation of Diffuse MIdline Glioma paTients	N/A
Withdrawn	`NCT03632317` - A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas	Phase 2
Completed	`NCT02502708` - Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors	Phase 1
Recruiting	`NCT02233049` - Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication	Phase 2
Completed	`NCT00996723` - Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)	Phase 1
Recruiting	`NCT05009992` - Combination Therapy for the Treatment of Diffuse Midline Gliomas	Phase 2
Recruiting	`NCT04049669` - Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG	Phase 2

NCT number	NCT05717712
Study type	Interventional
Source	Capital Medical University
Contact	Xiao Qian, Dr.
Phone	18020295435
Email	ryan521q@sina.com
Status	Recruiting
Phase	Phase 1
Start date	January 4, 2023
Completion date	January 4, 2028

Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms